Know Cancer

or
forgot password

Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV)


Phase 3
18 Years
65 Years
Not Enrolling
Both
Advanced Hodgkin Disease

Thank you

Trial Information

Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV)


Inclusion Criteria:



- Histologically confirmed diagnosis of Hodgkin disease

- Clinical stage IIB, III, IV

- No prior treatment for Hodgkin disease or other malignancy

- Age 18-65 year

- Good cardiac, pulmunar, renal and hepatic function

- Performance status 0-3 (Karnofsky 100- 40)

- Written Informed Consent

Exclusion Criteria:

- HIV positivity

- Large cell, anaplastic, CD30+ lymphoma

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

To compare the toxicity of the COPPEBVCAD vs BEACOPP vs ABVD regimens

Principal Investigator

Paolo Gobbi, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

GISL

Authority:

Italy: Ethics Committee

Study ID:

HD2000

NCT ID:

NCT00443677

Start Date:

April 2000

Completion Date:

June 2007

Related Keywords:

  • Advanced Hodgkin Disease
  • Hodgkin Disease

Name

Location